Mats Wahlstrom has bought stock on 2 days since Nov 2024
Director at TriSalus Life Sciences, Inc., and 1 other company
SEC CIK 0001459154 · Filings on SEC.gov ↗
Mats Wahlstrom's record
3 months after each buy, from the first price a copier could get.
2 buys have 3 months of prices so far. A record shows here at 3.
Companies
Every filing
6 filings since May 2016, newest first
Trisalus Life Sciences, Inc.
Director
Trisalus Life Sciences, Inc.
Director and 10% owner
Coherus Biosciences, Inc.
Director
Coherus Biosciences, Inc.
Director
Coherus Biosciences, Inc.
Director
Coherus Biosciences, Inc.
Director
About Mats Wahlstrom
Mats Wahlström
Mats Wahlström is a healthcare and life sciences executive who serves as Chairman of TriSalus Life Sciences, a role he has held since January 2017. He is also associated with several investment and operating entities, including KMG Capital Partners, Leonard Capital LLC, Caduceus Medical Holdings LLC, Physicians Capital Investments LLC, Somnia Sleep Wellness, and Triomed AB, reflecting a career spanning healthcare services, medical technology, and investment leadership ( He has also served as a lead independent director of Coherus Oncology and has held board roles at other healthcare companies, including Getinge AB and Alteco Medical AB (
Wahlström previously served as co-CEO of Fresenius Medical Care North America and as a member of the management board of Fresenius Medical Care AG & Co. KGAA from 2004 to 2009. Before that, he held senior leadership roles at Gambro AB, including President of Gambro North America, CEO of Gambro Healthcare Inc., and CFO of the Gambro Group. He earned a B.S. in Economics and Business Administration from the University of Lund in Sweden (
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.